8,11,14-Eicosatrienoic Acid
"8,11,14-Eicosatrienoic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5.
Descriptor ID |
D015126
|
MeSH Number(s) |
D10.251.355.255.207
|
Concept/Terms |
8,11,14-Eicosatrienoic Acid- 8,11,14-Eicosatrienoic Acid
- Dihomo-gamma-Linolenic Acid
- Acid, Dihomo-gamma-Linolenic
- Dihomo gamma Linolenic Acid
- Dihomogammalinolenic Acid
- Acid, Dihomogammalinolenic
- 8,11,14 Eicosatrienoic Acid
- DHLA
Homo-gamma Linolenic Acid- Homo-gamma Linolenic Acid
- Acid, Homo-gamma Linolenic
- Homo gamma Linolenic Acid
- Linolenic Acid, Homo-gamma
|
Below are MeSH descriptors whose meaning is more general than "8,11,14-Eicosatrienoic Acid".
Below are MeSH descriptors whose meaning is more specific than "8,11,14-Eicosatrienoic Acid".
This graph shows the total number of publications written about "8,11,14-Eicosatrienoic Acid" by people in UAMS Profiles by year, and whether "8,11,14-Eicosatrienoic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2025 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 | 2018 | 1 | 0 | 1 | 2017 | 1 | 0 | 1 | 2016 | 1 | 0 | 1 | 2015 | 1 | 1 | 2 | 2014 | 1 | 0 | 1 | 2013 | 2 | 0 | 2 | 2011 | 1 | 0 | 1 | 2010 | 1 | 0 | 1 | 2008 | 1 | 0 | 1 | 2006 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "8,11,14-Eicosatrienoic Acid" by people in Profiles over the past ten years.
-
de Bourg M, Mishra A, Mohammad RS, Morisseau C, Hammock BD, Imig JD, Vik A. Synthetic Epoxyeicosatrienoic Acid Mimics Protect Mesangial Cells from Sorafenib-Induced Cell Death. Molecules. 2025 Mar 24; 30(7).
-
Imig JD, Jankiewicz WK, Khan AH. Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture. Hypertension. 2020 07; 76(1):3-15.
-
Neck?r J, Hsu A, Hye Khan MA, Gross GJ, Nithipatikom K, Cyprov? M, Ben?k D, Hlav?ckov? M, Sot?kov?-Ka?parov? D, Falck JR, Sedmera D, Kol?r F, Imig JD. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1a via downregulation of prolyl hydroxylase 3. Am J Physiol Heart Circ Physiol. 2018 11 01; 315(5):H1148-H1158.
-
Campbell WB, Imig JD, Schmitz JM, Falck JR. Orally Active Epoxyeicosatrienoic Acid Analogs. J Cardiovasc Pharmacol. 2017 Oct; 70(4):211-224.
-
Sporkov? A, Reddy RN, Falck JR, Imig JD, Kopkan L, Sadowski J, Cervenka L. Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids. Am J Med Sci. 2016 05; 351(5):513-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|